361 related articles for article (PubMed ID: 32236239)
1. Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity.
Zhang B; Wan S; Peng X; Zhao M; Li S; Pu Y; He B
J Mater Chem B; 2020 May; 8(17):3939-3948. PubMed ID: 32236239
[TBL] [Abstract][Full Text] [Related]
2. Multi-stimuli responsive mesoporous carbon nano-platform gated by human serum albumin for cancer thermo-chemotherapy.
Zhao Q; Wang X; Yang M; Li X; Mao Y; Guan X; Di D; Wang S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110532. PubMed ID: 31590051
[TBL] [Abstract][Full Text] [Related]
3. A self-assembled pH/enzyme dual-responsive prodrug with PEG deshielding for multidrug-resistant tumor therapy.
Ni R; Zhu J; Xu Z; Chen Y
J Mater Chem B; 2020 Feb; 8(6):1290-1301. PubMed ID: 31967176
[TBL] [Abstract][Full Text] [Related]
4. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
[TBL] [Abstract][Full Text] [Related]
5. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer.
Xu C; Xu J; Zheng Y; Fang Q; Lv X; Wang X; Tang R
J Mater Chem B; 2020 Apr; 8(13):2726-2737. PubMed ID: 32154530
[TBL] [Abstract][Full Text] [Related]
6. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.
Xu Z; Yang D; Long T; Yuan L; Qiu S; Li D; Mu C; Ge L
Carbohydr Polym; 2022 Feb; 277():118827. PubMed ID: 34893244
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in Vitro Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline Derivatives.
Kimura K; Yamasaki K; Nakamura H; Haratake M; Taguchi K; Otagiri M
Chem Pharm Bull (Tokyo); 2018; 66(4):382-390. PubMed ID: 29607904
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
9. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy.
Qu J; Wang R; Peng S; Shi M; Yang ST; Luo JB; Lin J; Zhou QH
J Mater Chem B; 2019 Dec; 7(45):7129-7140. PubMed ID: 31663585
[TBL] [Abstract][Full Text] [Related]
10. Fabricating an intelligent cell-like nano-prodrug via hierarchical self-assembly based on the DNA skeleton for suppressing lung metastasis of breast cancer.
Li Y; Yan T; Chang W; Cao C; Deng D
Biomater Sci; 2019 Aug; 7(9):3652-3661. PubMed ID: 31169833
[TBL] [Abstract][Full Text] [Related]
11. Dual-triggered drug-release vehicles for synergistic cancer therapy.
Tu TY; Yang SJ; Tsai MH; Wang CH; Lee SY; Young TH; Shieh MJ
Colloids Surf B Biointerfaces; 2019 Jan; 173():788-797. PubMed ID: 30384276
[TBL] [Abstract][Full Text] [Related]
12.
Dong Y; Du P; Liu P
Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
[TBL] [Abstract][Full Text] [Related]
13. Prodrug-Based Nanoreactors with Tumor-Specific
Ren C; Liu H; Lv F; Zhao W; Gao S; Yang X; Jin Y; Tan Y; Zhang J; Liang XJ; Li Z
ACS Appl Mater Interfaces; 2020 Aug; 12(31):34667-34677. PubMed ID: 32610896
[TBL] [Abstract][Full Text] [Related]
14. Polymeric prodrug microspheres with tumor intracellular microenvironment bioreducible degradation, pH-triggered "off-on" fluorescence and drug release for precise imaging-guided diagnosis and chemotherapy.
Pei M; Li G; Ma K; Li J; Wang Y; Liu P
Colloids Surf B Biointerfaces; 2019 May; 177():313-320. PubMed ID: 30771583
[TBL] [Abstract][Full Text] [Related]
15. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
[TBL] [Abstract][Full Text] [Related]
16. Preparation of responsive "dual-lock" nanoparticles and their application in collaborative therapy based on CuS coordination.
Jia C; Zhang M; He XW; Li WY; Zhang YK
J Mater Chem B; 2021 Jan; 9(4):1049-1058. PubMed ID: 33399610
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
18. pH Responsiveness of Hexosomes and Cubosomes for Combined Delivery of
Li Y; Angelova A; Hu F; Garamus VM; Peng C; Li N; Liu J; Liu D; Zou A
Langmuir; 2019 Nov; 35(45):14532-14542. PubMed ID: 31635451
[TBL] [Abstract][Full Text] [Related]
19. A phosphorylcholine-based zwitterionic copolymer coated ZIF-8 nanodrug with a long circulation time and charged conversion for enhanced chemotherapy.
Xie R; Yang P; Peng S; Cao Y; Yao X; Guo S; Yang W
J Mater Chem B; 2020 Jul; 8(28):6128-6138. PubMed ID: 32568335
[TBL] [Abstract][Full Text] [Related]
20. Enhanced in vitro antitumor efficacy of a polyunsaturated fatty acid-conjugated pH-responsive self-assembled ion-pairing liposome-encapsulated prodrug.
Wang Y; Fan P; Zhu L; Zhuang W; Jiang L; Zhang H; Huang H
Nanotechnology; 2020 Apr; 31(15):155101. PubMed ID: 31846941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
